How we manage patients with indolent b-cell malignancies on bruton’s tyrosine kinase inhibitors: practical considerations for nurses and pharmacists

HIGHLIGHTS

  • who: Shannon Nixon and collaborators from the Centre, Toronto, M G , Canada have published the research work: How We Manage Patients with Indolent B-Cell Malignancies on Brutonu2019s Tyrosine Kinase Inhibitors: Practical Considerations for Nurses and Pharmacists, in the Journal: (JOURNAL) of 18/04/2023
  • what: Dose modifications not needed Suggest taking acetaminophen and caffeine Dose modifications typically not needed for mild cases; may be required for severe and persistent cases Suggest: - Increase fluid intake Small frequent meals Eat low-fiber, high calorie food (BRAT diet) Topical barrier cream for perianal area Take anti-diarrheal . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?